- Home
- LEDS vs CYCC Comparison
LEDS vs CYCC Comparison
Compare LEDS & CYCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LEDS
- CYCC
- Stock Information
- Founded
- LEDS 2005
- CYCC 1992
- Country
- LEDS Taiwan
- CYCC Malaysia
- Employees
- LEDS N/A
- CYCC N/A
- Industry
- LEDS Semiconductors
- CYCC Biotechnology: Pharmaceutical Preparations
- Sector
- LEDS Technology
- CYCC Health Care
- Exchange
- LEDS Nasdaq
- CYCC Nasdaq
- Market Cap
- LEDS 16.1M
- CYCC 17.5M
- IPO Year
- LEDS 2010
- CYCC N/A
- Fundamental
- Price
- LEDS $1.93
- CYCC $6.37
- Analyst Decision
- LEDS
- CYCC
- Analyst Count
- LEDS 0
- CYCC 0
- Target Price
- LEDS N/A
- CYCC N/A
- AVG Volume (30 Days)
- LEDS 67.5K
- CYCC 82.6K
- Earning Date
- LEDS 07-11-2025
- CYCC 11-11-2025
- Dividend Yield
- LEDS N/A
- CYCC N/A
- EPS Growth
- LEDS N/A
- CYCC N/A
- EPS
- LEDS N/A
- CYCC N/A
- Revenue
- LEDS $31,108,000.00
- CYCC $10,000.00
- Revenue This Year
- LEDS N/A
- CYCC $137.21
- Revenue Next Year
- LEDS N/A
- CYCC N/A
- P/E Ratio
- LEDS N/A
- CYCC N/A
- Revenue Growth
- LEDS 485.62
- CYCC N/A
- 52 Week Low
- LEDS $0.92
- CYCC $3.08
- 52 Week High
- LEDS $3.16
- CYCC $597.60
- Technical
- Relative Strength Index (RSI)
- LEDS 53.82
- CYCC 37.28
- Support Level
- LEDS $1.61
- CYCC $5.92
- Resistance Level
- LEDS $1.91
- CYCC $8.82
- Average True Range (ATR)
- LEDS 0.17
- CYCC 0.58
- MACD
- LEDS 0.03
- CYCC -0.04
- Stochastic Oscillator
- LEDS 28.32
- CYCC 15.52
About LEDS SemiLEDS Corporation
SemiLEDs Corp develops, manufactures, and sells light-emitting diode chips and LED components. The company's products include LED Chips, LED Components, and Lighting Products. Its products are used for general lighting applications, including street lights and commercial, industrial, system, and residential lighting; specialty industrial applications, such as ultraviolet, or Ultraviolet, curing of polymers, LED light therapy in medical/cosmetic applications, counterfeit detection, LED lighting for horticulture applications, architectural lighting and entertainment lighting. Substantial revenue is generated from the sale of LED components products. Geographically, it derives a majority of its revenue from Japan.
About CYCC Cyclacel Pharmaceuticals Inc.
Cyclacel Pharmaceuticals Inc is a clinical-stage biopharmaceutical company that develops targeted medicines for cancer and other proliferative diseases. The company develops several families of anticancer drugs that act on the cell cycle, including CDK (cyclin-dependent kinase) inhibitors and PLK (polo-like kinase) inhibitors. The pipeline development programs of the company include fadraciclib and plogosertib. The company derives its revenue from United Kingdoms.